single domain antibody

Creative Biolabs has established the novel sdAb production platforms that enable the generation of target-specific single domain antibodies within 8 weeks. We have produced a large number of single domain antibodies with high affinity and specificity against a large number of distinct targets, including cytokines, cell surface receptors, tumor cell markers, viral antigens, and enzymes. Of note, single domain antibodies are perfectly stable polypeptides harboring the full antigen-binding capacity of conventional antibodies. This unique structural and functional property render these molecules ideal candidates for new generation of antibody therapeutics.

To meet the special needs of our clients on single domain antibody, Creative Biolabs has combined our cutting-edge techniques with advanced phage display technology to offer a series of services including sdAb library construction, screening, and sdAb production. Our scientists are confident in tailoring the most appropriate protocol to develop high-quality single domain antibodies for our clients’ research purpose.